Top Movers

GSK to sell remaining 4.2% stake in Haleon

By Michele Maatouk

Date: Thursday 16 May 2024

GSK to sell remaining 4.2% stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
The pharmaceutical company will sell about 385m ordinary shares in consumer health business Haleon, which it spun off in July 2022.

GSK initially retained a 12.9% stake in Haleon, but has since sold stakes in May 2023, October 2023 and January 2024.

The final disposal will be conducted through a placing of ordinary shares to institutional investors. GSK said the offer price will be determined by means of an accelerated bookbuild offering process which will start immediately.


Email this article to a friend

or share it with one of these popular networks:

Top of Page